Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04116541
Title A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. (MegaMOST)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Leon Berard
Indications

Advanced Solid Tumor

Therapies

Alectinib

Cabozantinib

HDM201 + Ribociclib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST